GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
NCT: NCT07166133 · RECRUITING
Publicidad
Resumen breve
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Fuente oficial
Ver en ClinicalTrials.gov →Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.